• Explore /
  • Poster
  • / Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting.

Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting.

Abstract Poster

Authors

null

Bahar Saberzadeh Ardestani

Mayo Clinic, Rochester, MN

Bahar Saberzadeh Ardestani , Jeremy Clifton Jones , Robert R. McWilliams , David Tougeron , Thorvardur Ragnar Halfdanarson , Rosine Guimbaud , Joleen M. Hubbard , Clémence Flecchia , Qian Shi , Emily Linda Alouani , Bassam Bassam Sonbol , Jonathan Ticku , Zhaohui Jin , Julien Taieb , Frank A. Sinicrope

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 55)

DOI

10.1200/JCO.2024.42.3_suppl.55

Abstract #

55

Poster Bd #

D18

Abstract Disclosures

Similar Posters

First Author: Federica Marmorino

First Author: Manish Sharma

First Author: Ru Jia

First Author: Marc Eid